Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $107,181,055    

Indirect Value

   $148,967,432      
Total Shares   53,734,364      
Total Value   $256,148,487      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,471,487 Rapt Therapeutics, Inc. $20,776,534 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $83,933,035 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,471,487 Rapt Therapeutics, Inc. $20,776,534 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $83,933,035 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-12 4 B $4.95 $26,603 I/I 5,378 694,920 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-08-05 4 B $13.98 $81,400 I/I 5,824 16,131,933 2.25 -
NGM Ngm Biopharmaceuticals In...   –       •       •   2023-11-16 4 B $0.62 $3,627 I/I 5,840 949,862 0.01 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-19 4 B $13.99 $87,043 I/I 6,222 15,942,285 2.25 -
TNYA Tenaya Therapeutics, Inc. Director   –       •       •   2023-03-10 4 B $2.60 $17,596 I/I 6,779 11,377,053 2.17 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-10-17 4 B $10.62 $72,407 I/I 6,818 16,519,897 2.25 -
RVMD Revolution Medicines, Inc... Managing Partner   –       –       •   2020-06-17 4 A $0.00 $0 I/I 7,234 7,234 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-12 4 B $14.00 $104,989 I/I 7,500 15,815,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-30 4 B $5.00 $37,707 I/I 7,542 750,501 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-05 4 B $18.00 $149,526 I/I 8,307 16,802,351 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-11-04 4 B $11.99 $100,824 I/I 8,409 16,610,814 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-30 4 B $13.91 $123,195 I/I 8,855 16,121,727 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2023-01-23 4 B $5.00 $49,494 I/I 9,900 742,959 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-04 4 B $17.96 $179,349 I/I 9,986 16,794,044 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-14 4 B $14.00 $150,687 I/I 10,760 15,837,474 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-07-11 4 B $13.87 $150,752 I/I 10,870 15,894,961 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-11 4 B $13.83 $150,718 I/I 10,900 15,807,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-13 4 B $14.13 $162,508 I/I 11,500 15,826,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-24 4 B $13.78 $168,650 I/I 12,240 15,884,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-04 4 B $13.39 $168,764 I/I 12,600 15,771,614 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-06 4 B $13.40 $168,884 I/I 12,600 15,784,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-07 4 B $13.66 $172,176 I/I 12,600 15,796,814 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-03-02 4 B $17.90 $252,820 I/I 14,124 16,745,300 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-03 4 B $12.41 $181,025 I/I 14,587 17,660,648 2.25 %
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2020-04-02 4 B $12.40 $184,140 I/I 14,850 17,646,061 2.25 %
  145  Records found
  1   2  3   4   5   6      
  Page 2 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us